article thumbnail

Report: MA Enrollment Has Quadrupled in Rural Communities Since 2010

MedCity News

In rural areas, the share of eligible beneficiaries enrolled in MA plans nearly quadrupled from 11% in 2010 to 40% in 2023, according to new research from KFF. This represents 400,000 rural MA beneficiaries in 2010 and 1.8 million in 2023.

article thumbnail

NIH spending for drugs approved 2010-2019 lower than industry spending, study finds

European Pharmaceutical Review

billion for phased clinical trials of US Food and Drug Administration (FDA)-approved drugs between 2010-2019. million publications describing basic or applied research related to 386 of 387 drugs approved 2010-2019 with $8.1 This was ~10 percent of reported industry spending. billion (3.3

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Don’t blame mental health for mass murder

World of DTC Marketing

According to the National Institutes of Health, people with a mental health diagnosis committed less than 5 percent of gun-related homicides between 2001 and 2010.

article thumbnail

Do patients care about accelerated approval drugs?

World of DTC Marketing

85% of accelerated approvals from 2010 to 2020 were for oncology indications. of approvals), cancer (35.6%), and other rare diseases (24.7%). Since then, accelerated Approval has shifted focus to oncology drugs.

Patients 200
article thumbnail

Strategic Planning Links for Easy Access to the Entire Series

Medical Device Success

Getting from A to E www.medicaldevicesuccess.com/2010/11/18/getting-from-a-to-e/. Qualitative Benefits of Strategic Planning www.medicaldevicesuccess.com/2010/11/18/qualitative-benefits-of-strategic-planning/. Assumptions www.medicaldevicesuccess.com/2010/12/03/assumptions-–-defy-the-old-saying-that-results-in-“ass-u-me”/.

Medical 100
article thumbnail

Pharma’s outdated hiring practices

World of DTC Marketing

The average time it takes to fill an open position is 44 days, representing a 50-percent increase since 2010. If you know what kind of profile you’re searching for, go for it and contact the best candidates immediately. Each day a job goes unfilled, the organization loses productivity as the position’s tasks remain undone.

Pharma 277
article thumbnail

The future of pain medication: are cannabinoids the solution to the opioid epidemic?

Pharmaceutical Technology

Currently, Jazz Pharmaceuticals’s nabiximols is the only cannabinoid approved for pain, receiving approval in Israel, in August 2010. In 2022, Pfizer acquired the drug, with the promise of accelerating clinical development via new, differentiated, and best-in-class approaches, enhancing optimism for further drug development.

Medical 143